help button home button Am J Pathol ASIP 2008 Summer Academy, Molecular Methcanisms of Human Disease: Injury, Inflammation, and Tissue Repair
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de la Monte, S. M.
Right arrow Articles by Moore, G. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de la Monte, S. M.
Right arrow Articles by Moore, G. W.

American Journal of Pathology, Vol 114, 131-136, Copyright © 1984 by American Society for Investigative Pathology


REGULAR ARTICLES

Endocrine organ metastases from breast carcinoma

SM de la Monte, GM Hutchins and GW Moore

Breast carcinoma frequently metastasizes to endocrine organs, a behavior which may have prognostic or therapeutic relevance. Whether endocrine organ involvement represents a trophic influence on some carcinomas or is simply a "mass effect" of tumor dissemination is uncertain. To investigate this question, the authors reviewed the clinical and pathologic features of 187 subjects with metastatic breast carcinoma, all of whom had been subjected to complete autopsy at The Johns Hopkins Hospital. Metastases to primary endocrine organs, ie, the anterior pituitary, thyroid, parathyroid, or adrenal cortex, occurred in 57%, and metastases to secondary endocrine organs, ie, the pineal, posterior pituitary, thymus, adrenal medulla, or pancreas, occurred in 62% of patients. In general, patients with endocrine organ metastases were significantly younger and had significantly greater numbers of metastases and greater overall tumor burden than those without endocrine organ metastases (all P less than 0.001). There was no correlation between endocrine organ metastases and survival, therapy, histologic type of tumor, or grade of anaplasia or desmoplasia. Metastases to primary endocrine organs were correlated with one another and with metastases in secondary endocrine organs. Metastases in secondary endocrine organs were intercorrelated and also correlated with several nonendocrine organs, chiefly the heart, liver, and gut (all P less than 0.005). These findings indicate that metastases of breast carcinoma to endocrine organs occur in a setting of widely disseminated tumor. However, the observed correlations among metastatic sites suggest that the distributions are nonrandom; these distributions may reflect fundamental properties of some breast carcinomas with respect to hormone receptors, biologic behavior, or environmental growth requirements.


This article has been cited by other articles:


Home page
J. Clin. Pathol.Home page
L Venkatraman, A Kalangutkar, and C F Russell
Primary hyperparathyroidism and metastatic carcinoma within parathyroid gland
J. Clin. Pathol., September 1, 2007; 60(9): 1058 - 1060.
[Full Text] [PDF]


Home page
RadioGraphicsHome page
K. J. To'o, S. S. Raman, N. C. Yu, Y. J. Kim, T. Crawford, B. M. Kadell, and D. S. K. Lu
Pancreatic and Peripancreatic Diseases Mimicking Primary Pancreatic Neoplasia
RadioGraphics, July 1, 2005; 25(4): 949 - 965.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
H. M. Khandwala, D. Mirchandani, R. Chibbar, and V. Chow
Uncommon Presentations of Cancer Patients: CASE 1. Metastatic Breast Cancer Presenting With Panhypopituitarism
J. Clin. Oncol., December 1, 2004; 22(23): 4851 - 4853.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1984 by the American Society for Investigative Pathology.